Heparin Dosing for DVT Prophylaxis in Patients Over 75 Years
For adults over 75 years requiring DVT prophylaxis, administer unfractionated heparin 5,000 units subcutaneously every 8 hours, which is the standard prophylactic regimen regardless of age. 1
Standard Prophylactic Dosing
- The recommended dose is 5,000 units subcutaneously every 8 hours (three times daily), which provides superior DVT prevention compared to twice-daily dosing. 1, 2
- The three-times-daily regimen is specifically endorsed for cancer patients and surgical patients, and maintains more consistent anticoagulant levels throughout the day. 1, 2, 3
- Twice-daily dosing (5,000 units every 12 hours) is less effective and should be avoided when optimal prophylaxis is needed. 3
Age-Specific Considerations for Patients Over 75 Years
- No dose reduction is required based solely on age over 75 years. 4
- The FDA label states that "patients over 60 years of age may require lower doses of heparin," but this is a general statement without specific dosing recommendations, and guideline evidence supports standard dosing. 4
- Older patients may have higher serum heparin levels and longer aPTT compared to younger patients, but prophylactic dosing does not require aPTT monitoring. 1
Critical Monitoring Requirements
- Check platelet counts every 2-3 days from day 4 through day 14 to screen for heparin-induced thrombocytopenia (HIT). 1, 5
- Monitor hemoglobin, hematocrit, and signs of bleeding throughout therapy. 1
- If platelets fall below 50 × 10⁹/L, strongly consider discontinuing prophylactic anticoagulation. 5
Duration and Timing
- Initiate prophylaxis 2 hours before surgery for surgical patients to achieve adequate anticoagulation at the time of greatest thrombotic risk. 2, 6, 4
- Continue for at least 7-10 days postoperatively or until the patient is fully ambulatory, whichever is longer. 1, 2, 4
- For medical patients, continue prophylaxis throughout hospitalization until fully ambulatory. 1, 2
Special Circumstances in Elderly Patients
Renal Impairment
- Unfractionated heparin is the preferred agent when creatinine clearance is <30 mL/min, as it is primarily metabolized by the liver rather than renally excreted. 1, 2, 6
- Standard dosing of 5,000 units every 8 hours can be used without dose adjustment in renal failure. 5, 6
Bleeding Risk Assessment
- Fondaparinux should be used with caution in patients >75 years with moderate renal insufficiency (CrCl 30-50 mL/min), weight <50 kg, or age >75 years. 1
- For elderly patients at high bleeding risk, mechanical prophylaxis (graduated compression stockings and/or intermittent pneumatic compression) should be used until bleeding risk diminishes. 1
Critical Pitfalls to Avoid
- Do not confuse prophylactic dosing (5,000 units every 8 hours) with therapeutic dosing (80 U/kg bolus followed by 18 U/kg/hour infusion), which requires aPTT monitoring. 1, 6
- Avoid administering anticoagulants within 10-12 hours of neuraxial anesthesia due to spinal hematoma risk. 5, 6
- Do not use unfractionated heparin in patients with active or history of heparin-induced thrombocytopenia; use a direct thrombin inhibitor or fondaparinux instead. 5
- Do not reduce the dose to 5,000 units twice daily in elderly patients, as this provides inadequate prophylaxis. 3
Alternative Agents (When UFH is Contraindicated)
- Enoxaparin 40 mg subcutaneously once daily is an alternative, but requires dose reduction to 30 mg once daily if CrCl <30 mL/min. 1, 2
- Dalteparin 5,000 IU subcutaneously once daily is another option. 1
- Fondaparinux 2.5 mg subcutaneously once daily, but use with extreme caution in patients >75 years with renal impairment. 1